Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs7015229 | chr8:124077305 | A/G | 6.29E-5 | 133 | 37.3 | 49.93 | 56.7 | KM Plot |
| TGCT | rs7071670 | chr10:1105473 | T/A | 1.75E-13 | 133 | 41.27 | 70.63 | 17.1 | KM Plot |
| TGCT | rs7080500 | chr10:1129814 | C/T | 1.2E-5 | 134 | 45.7 | 36.87 | 33.52 | KM Plot |
| TGCT | rs7093915 | chr10:1107341 | A/G | 5.23E-7 | 134 | 17.58 | 70.63 | 42.03 | KM Plot |
| TGCT | rs70990113 | chr6:42591881 | GT/G | 2.46E-8 | 134 | 37.95 | 49.93 | 20.6 | KM Plot |
| TGCT | rs7100114 | chr10:1110231 | A/G | 1.36E-13 | 134 | 41.97 | 70.63 | 17.1 | KM Plot |
| TGCT | rs7112744 | chr11:10557871 | A/T | 5.62E-5 | 133 | 46.3 | 21.6 | 43.73 | KM Plot |
| TGCT | rs7114800 | chr11:130969410 | C/T | 7.83E-7 | 134 | 0.57 | 54.57 | 41.97 | KM Plot |
| TGCT | rs71177450 | chr19:37936839 | G/GA | 2.27E-13 | 132 | 45.1 | 36.12 | 17.1 | KM Plot |
| TGCT | rs71202404 | chr13:21845468 | T/TTAAGA | 8.52E-7 | 129 | 46.3 | 37.3 | 14.42 | KM Plot |
| TGCT | rs71235144 | chr7:76517567 | C/A | 0.000102 | 128 | 41.97 | 49.93 | 10.62 | KM Plot |
| TGCT | rs71310525 | chr3:172536130 | A/T | 5.03E-5 | 134 | 42.03 | 41.92 | 47.38 | KM Plot |
| TGCT | rs7133161 | chr12:107139540 | A/G | 0.000113 | 133 | 42.27 | 45.1 | 28.8 | KM Plot |
| TGCT | rs71396994 | chr2:3485045 | A/AT | 2.2E-5 | 132 | 40.57 | 57.87 | 25.32 | KM Plot |
| TGCT | rs71526077 | chr7:128623792 | A/ACAGCCCATCTTTT | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |